Restoration of platelet aggregation by antibody administration after GPIIB/IIIa antagonist treatment

摘要

The invention provides a process to restore platelet aggregation by the administration of antibody combining site-containing molecules that specifically bind to a specific class of reversibly-bound GPIIb/IIIa fibrinogen receptor antagonist compounds.